Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Inventory Average (2016 - 2025)

Angiodynamics (ANGO) has disclosed Inventory Average for 15 consecutive years, with $63.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average fell 2.14% year-over-year to $63.9 million, compared with a TTM value of $63.9 million through Nov 2025, down 2.14%, and an annual FY2025 reading of $61.3 million, up 5.76% over the prior year.
  • Inventory Average was $63.9 million for Q4 2025 at Angiodynamics, up from $62.1 million in the prior quarter.
  • Across five years, Inventory Average topped out at $65.3 million in Q4 2024 and bottomed at $48.1 million in Q1 2022.
  • Average Inventory Average over 5 years is $57.6 million, with a median of $59.9 million recorded in 2022.
  • The sharpest move saw Inventory Average fell 14.97% in 2021, then surged 31.68% in 2023.
  • Year by year, Inventory Average stood at $48.7 million in 2021, then increased by 23.9% to $60.4 million in 2022, then grew by 2.85% to $62.1 million in 2023, then rose by 5.15% to $65.3 million in 2024, then dropped by 2.14% to $63.9 million in 2025.
  • Business Quant data shows Inventory Average for ANGO at $63.9 million in Q4 2025, $62.1 million in Q3 2025, and $62.6 million in Q2 2025.